HB446
Known as:
Bill’s Next Stop:
Signed by Governor March 7, 2022
The bill sponsor says this will…
…make nabiximols, a cannabis derivative, available for prescription upon FDA and DEA approval.
Potential implications of this bill are…
...to increase the number of non-toxic drugs available to Idahoans who suffer from MS and other neurological conditions.
How I’m voting/How I voted:
Yes